Efficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Most current methods for identifying peptides that are bound to a distinct MHC-I product in a given cell sample utilize detergent solubilization of membrane proteins followed by immunoaffinity purification. Since detergent traces and cell debris hamper subsequent peptide analysis, exceedingly large cell samples are often required. To avoid the use of detergents, truncated MHC-I heavy chains have recently been expressed by stable DNA transfection or retroviral transduction, resulting in the secretion of soluble MHC-I complexes to the growth medium. The electroporation of in vitro-transcribed mRNA achieves remarkable efficacy and uniformity of gene expression in numerous cell types, exhibiting exceedingly fast kinetics. We reasoned that mRNA transfection offers a simple, fast and widely applicable alternative to current gene delivery protocols for expressing secreted MHC-I products in cells of interest. To test this assumption we used mRNA to express soluble derivatives of HLA-A2 in the human AF10 B cell myeloma and 624mel melanoma and H-2K(d) in the mouse SP2/0 B cell myeloma. The level of MHC-I complexes secreted by these cells peaked within less than 24h post-transfection and they could be affinity-purified directly from the culture medium in considerably greater yields when compared to nonionic detergent lysates on a cell-to-cell basis. Mass-spectrometry analysis of eluted peptides revealed larger pools in the secreted material than in lysates with substantial overlap in composition. Our results introduce mRNA transfection as a powerful tool for determining the cell's MHC-I peptidome, which can be potentially applied to a broad range of cell types.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., et al. (2014) · Nature · doi:10.1038/nature14001 · Cited by 1,186
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625
The Clinical Relevance of Cancer Cell Lines
Gillet, J.-P., Varma, S., & Gottesman, M. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt007 · Cited by 599
Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.
Topalian, S. L., Solomon, D., & Rosenberg, S. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.10.3714 · Cited by 526
Zhao, Y., Moon, E., Carpenito, C., Paulos, C. M., Liu, X., Brennan, A. L., Chew, A., Carroll, R. G., Scholler, J., Levine, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2880 · Cited by 450
Nilsson, K., Bennich, H., Johansson, S. G. O., & Pontén, J. (1970) · PubMed Central · Cited by 411
Boczkowski, D., Nair, S. K., Nam, J., Lyerly, H. K., & Gilboa, E. (2000) · PubMed · Cited by 343
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Rajasagi, M., Shukla, S. A., Fritsch, E. F., Keskin, D. B., DeLuca, D., Carmona, E., Zhang, W., Sougnez, C., Cibulskis, K., Sidney, J., et al. (2014) · Blood · doi:10.1182/blood-2014-04-567933 · Cited by 309
Falk, K., Rötzschke, O., Deres, K., Metzger, J., Jung, G., & Rammensee, H. G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.2.425 · Cited by 266
Solomon, A., Frangione, B., & Franklin, E. C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110635 · Cited by 257
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Friese, M. A., & Fugger, L. (2005) · Brain · doi:10.1093/brain/awh578 · Cited by 251
Expression of T Cell Antigen Receptor Heterodimers in a Lipid-Linked Form
Lin, A. Y., Devaux, B., Green, A., Sagerström, C. G., Elliott, J. F., & Davis, M. M. (1990) · Science · doi:10.1126/science.1696397 · Cited by 226
Antigen Targets of Type 1 Diabetes Autoimmunity
Roep, B. O., & Peakman, M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007781 · Cited by 210
Autoreactive CD8 T Cells in Organ-Specific Autoimmunity
Liblau, R. S., Wong, F. S., Mars, L. T., & Santamaria, P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00338-2 · Cited by 206
Prospects for Vaccine Protection Against HIV-1 Infection and AIDS
Letvin, N. L., Barouch, D. H., & Montefiori, D. C. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.094854 · Cited by 179
Storkus, W. J., Zeh, H. J., Salter, R. D., & Lotze, M. T. (1993) · Journal of Immunotherapy · doi:10.1097/00002371-199308000-00003 · Cited by 172
The MHC class I peptide repertoire is molded by the transcriptome
Fortier, M.-H., Caron, E., Hardy, M.-P., Voisin, G., Lemieux, S., Perreault, C., & Thibault, P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071985 · Cited by 171
Identification of T-cell epitopes for cancer immunotherapy
Kessler, J. H., & Melief, C. J. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404787 · Cited by 125
CD8+T cells in multiple sclerosis
Đenić, A., Wootla, B., & Rodriguez, M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.815726 · Cited by 122
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Bassani-Sternberg, M., Barnea, E., Beer, I., Avivi, I., Katz, T., & Admon, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008501107 · Cited by 121
Self-citationLoffredo, J. T., Sidney, J., Bean, A. T., Beal, D. R., Bardet, W., Wahl, A. R., Hawkins, O. E., Piaskowski, S. M., Wilson, N. A., Hildebrand, W. H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900111 · Cited by 112
Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire
Hickman, H. D., Luis, A. D., Buchli, R., Few, S. R., Sathiamurthy, M., VanGundy, R. S., Giberson, C. F., & Hildebrand, W. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2944 · Cited by 110
Barnea, E., Beer, I., Patoka, R., Ziv, T., Kessler, O., Tzehoval, E., Eisenbach, L., Zavazava, N., & Admon, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1<213::aid-immu213>3.0.co;2-8 · Cited by 92
Self-citationT Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives
Mallone, R., Brezar, V., & Boîtard, C. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/513210 · Cited by 87
From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens
Schultze, J. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02015-4 · Cited by 86
Dror, L. B., Barnea, E., Beer, I., Mann, M., & Admon, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27257 · Cited by 77
Self-citationBiochemical Large-Scale Identification of MHC Class I Ligands
Kowalewski, D. J., & Stevanović, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-218-6_12 · Cited by 76
Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection
Hickman, H. D., Luis, A. D., Bardet, W., Buchli, R., Battson, C. L., Shearer, M. H., Jackson, K. W., Kennedy, R. C., & Hildebrand, W. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.22 · Cited by 76
McMurtrey, C., Lelic, A., Piazza, P. A., Chakrabarti, A. K., Yablonsky, E. J., Wahl, A. R., Bardet, W., Eckerd, A., Cook, R. L., Hess, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711874105 · Cited by 70
Large-scale production of class I bound peptides: assigning a signature to HLA-B * 1501
Prilliman, K. R., Lindsey, M., Zuo, Y., Jackson, K. W., Zhang, Y., & Hildebrand, W. H. (1997) · Immunogenetics · doi:10.1007/s002510050219 · Cited by 66
HLA class I molecules consistently present internal influenza epitopes
Wahl, A., Schafer, F., Bardet, W., Buchli, R., Air, G. M., & Hildebrand, W. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811271106 · Cited by 60
Identification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201
Hawkins, O. E., VanGundy, R. S., Eckerd, A., Bardet, W., Buchli, R., Weidanz, J. A., & Hildebrand, W. H. (2008) · Journal of Proteome Research · doi:10.1021/pr700761w · Cited by 56
Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands
Scull, K. E., Dudek, N. L., Corbett, A. J., Ramarathinam, S. H., Gorasia, D. G., Williamson, N. A., & Purcell, A. W. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.02.117 · Cited by 49
Admon, A., Barnea, E., & Ziv, T. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r300004-mcp200 · Cited by 48
Self-citationHaen, S. P., & Rammensee, H. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.007 · Cited by 42
Margulies, D. H., Ramsey, A. L., Boyd, L. F., & McCluskey, J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5252 · Cited by 42
Human cancer regression antigens
Kvistborg, P., van Buuren, M. M., & Schumacher, T. N. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.005 · Cited by 40
Hassner, A., & Saxon, A. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2844 · Cited by 40
Membrane-Anchored β2-Microglobulin Stabilizes a Highly Receptive State of MHC Class I Molecules
Berko, D., Carmi, Y., Cafri, G., Ben-Zaken, S., Migalovich-Sheikhet, H., Tzehoval, E., Eisenbach, L., Margalit, A., & Gross, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2116 · Cited by 38
Self-citationWeidanz, J. A., Piazza, P. A., Hickman, H. D., Woodburn, D., Nguyen, T. T. M., Wahl, A. R., Neethling, F. A., Chiriva‐Internati, M., Rinaldo, C. R., & Hildebrand, W. H. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.09.019 · Cited by 27
Hellman, L., Josephson, S., Jernberg, H., Nilsson, K., & Pettersson, U. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180611 · Cited by 27
Complexity among constituents of the HLA-B*1501 peptide motif
Prilliman, K. R., Lindsey, M., Jackson, K. W., Cole, J., Bonner, R. F., & Hildebrand, W. H. (1998) · Immunogenetics · doi:10.1007/s002510050408 · Cited by 26
CD8 + T-Cell Response Against Hepatitis C Virus
He, X.-S., & Greenberg, H. B. (2002) · Viral Immunology · doi:10.1089/088282402317340279 · Cited by 20
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells
Wahl, A. R., Weidanz, J. A., & Hildebrand, W. H. (2006) · Expert Review of Proteomics · doi:10.1586/14789450.3.6.641 · Cited by 20
Large-scale analysis of HLA peptides presented by HLA-Cw4
Buchsbaum, S., Barnea, E., Dassau, L., Beer, I., Milner, E., & Admon, A. (2003) · Immunogenetics · doi:10.1007/s00251-003-0570-0 · Cited by 18
Self-citationPeptide motif of the class I molecule HLA-B*1503
Prilliman, K. R., Lindsey, M., Wang, J., Jackson, K. W., & Hildebrand, W. H. (1999) · Immunogenetics · doi:10.1007/s002510050474 · Cited by 9
Berg, M., Barnea, E., Admon, A., & Zavazava, N. (2004) · International Journal of Cancer · doi:10.1002/ijc.20381 · Cited by 4
Self-citationFlies, A., Ahmadi, T., Parks, A. J., Prokaeva, T. B., Weng, L., Rolfe, S. S., Seldin, D. C., & Sherr, D. H. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.73 · Cited by 3
Cited by
Zhang, X., Qi, Y., Zhang, Q., & Liu, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109542 · Cited by 62
Ritz, D., Gloger, A., Weide, B., Garbe, C., Neri, D., & Fugmann, T. (2016) · PROTEOMICS · doi:10.1002/pmic.201500445 · Cited by 61
Purification and Identification of Naturally Presented MHC Class I and II Ligands
Nelde, A., Kowalewski, D. J., & Stevanović, S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9450-2_10 · Cited by 58
Qi, Y. A., Maity, T. K., Cultraro, C. M., Misra, V., Zhang, X., Ade, C. M., Gao, S., Milewski, D., Nguyen, K. D. P., Ebrahimabadi, M. H., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100136 · Cited by 47
Critical Review of Existing MHC I Immunopeptidome Isolation Methods
Kuznetsov, A. A., Voronina, A. K., Govorun, V. M., & Arapidi, G. P. (2020) · Molecules · doi:10.3390/molecules25225409 · Cited by 40
Metadata
- Authors
- Lazarus, D., Weinstein-Marom, H., Fishman, S., Yossef, R., Zuri, D., Barnea, E., Admon, A., Margalit, A., & Gross, G.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Migal - Galilee Technology Center (IL)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gross, Gideon
- Venue
- Immunology Letters
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 165
- Issue
- 1
- Pages
- 32-38
- ISSN
- 0165-2478 (ISSN-L)
- OpenAlex
- W2027641497
- Cited by
- 7
- References
- 51
- Citations by year
- 2023: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2016: 1
- FWCI
- 0.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Immunology Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- MHC class I, peptide recovery, mRNA transfection, electroporation, HLA-A2, H-2Kd, melanoma, affinity purification
- MeSH terms
- Animals, Cell Line, Flow Cytometry, Humans, Peptides, Recombinant Proteins, RNA, Messenger, Transfection, Histocompatibility Antigens Class I, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.